Psoriatic Arthritis
Original Editors - Students from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Lead Editors - Your name will be added here if you are a lead editor on this page. Read more.
Definition/Description[edit | edit source]
Psoritic arthritis is a chronic progressive immunologic disease that causes joint inflammation. It is a seronegative spondyloarthopathy that often coincides with psoriasis. In around 70% of cases, psoriasis precedes the arthritis. For the majority, joint symptoms do not apear until approximately ten years after the first signs of psoriasis. Both occur simultaneously in 15% of cases. Arthrits occassionally will appear first in around 15% of cases. Expression of the disease varies greatly from one person to the next. Its course is unpredictable and can range from mild to severe and destructive. The DIP joints are often involved bilaterally. Psoriatic arthritis causes inflammation, pain, stiffness, and swelling in joints as well as ligaments and tendons at their insertion site into bone. Bone, tendons, enthesis, cartilage, synovial membrane, skin, and nails may all be affected by the condition. Marked joint destruction may occur in some individuals. After two years joint damage will commonly appear on radiographs and may include bone erosion, narrowing of joint space, periostitis, osteolysis, acro-osteolysis, ankylosis, spur formation, and spondylitis. Diagnosis of this condition may often be delayed since there are no identified biomarkers at this time.[1] If left untreated psoriatic arthritis may lead to severe physical limitations and disability.[2]
Prevalence[edit | edit source]
- Occurs in 6%-42% of persons that have psoriasis
- Approximately 2% of general population has psoriasis
- Psoriatic arthritis is estimated to have a prevalence of 0.1%-0.25% in the US
- Equal prevalence in both males and females [3]
- Can occur at any age but typically occurs between ages of 30-50 years old
Characteristics/Clinical Presentation[edit | edit source]
add text here
Associated Co-morbidities
- Psoriasis
- Presence of HLA-B27
Medications[edit | edit source]
- NSAIDS
- Local Corticosteroid Injections
Aggressive Cases
- DMARD Therapy with MTX, SSZ, and TNF-Beta Antagonists [3]
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
- There is no definitive test. Diagnosis is made by ruling out other conditions.
- X-rays are often performed to detect bone erosion. However, signs of psoriatic arthritis often do not appear on X-ray until two years into the disease.
- DIP erosive changes on X-rays may support the diagnosis.Cite error: The opening
<ref>tag is malformed or has a bad name - Blood work will be done to detect for the HLA-B27 since it is a common histocompatibility complex marker in people with psoriatic arthritis.
- A blood test for rheumatoid factor should be done to rule out rheumatoid arthritis
Causes[edit | edit source]
Psoriatic arthritis seems to have a genetic cause although the exact marker genes have not been identified. Having a first-degree realtive with psoriatic arthritis increases the likihood of contracting the disease by 80-90%.[3]
Medical Management[edit | edit source]
- Narrowband UVB light therapy can be very effective in clearing skin lesions. Bulbs with a narrow emission between 311 and 313 nm have been shown in studies to be superior to broadband UVB light. Treatment can be done in an outpatient setting or at home. Both small handheld devices are available as well as larger full body light units. UV light lamps designed specifically for psoriasis are more effective than commercial tanning beds or sunlight since they give of narrowband UVB light. Commercial tanning beds often give off much higher levels of UVA radiation that has been proven to be less effective in treating psoriasis. Exact ratios of UVA and UVB are very difficult to determine with both sunlight and tanning beds. Generally light treatments should be done 2-3 times per week for a total of around twenty-five treatments. Skin will be exposed to UVB light from 20 seconds up to around 2 minutes during each treatment based on the Fitzpatrick skin type or minimal erythema dose. [2]
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Alternative/Holistic Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
- Osteoarthritis
- Rheumatoid Arthritis
- Reactive Arthritis
- Gaut
- Mallet finger due to traumatic injury
Case Reports[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10
[3][4][1][5]References [6][7][edit | edit source]
see adding references tutorial.
- ↑ 1.0 1.1 Anandarajah AP, Ritchlin CT. The diagnosis and treatment of early psoriatic arthritis. Nat. Rev. Rheumatol. 2009;5:634-641.
- ↑ 2.0 2.1 Cite error: Invalid
<ref>tag; no text was provided for refs namedMenter A, et al - ↑ 3.0 3.1 3.2 3.3 Fuller KS. Pathology: Implications for the Physical Therapist. Third Edition. St.Louis: Saunders Elsevier; 2009.
- ↑ Gottlieb A, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 2. Psoriatic arthritis:overview and guidelines of care for treatment with an emphasis on biologics. Journal of the American Academy of Dermatology. 2008;58:851-864.
- ↑ Menter A, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treament of psoriasis with phototherapy and photochemotherapy. Journal of the American Academy of Dermatology. 2010;62(1):114-135.
- ↑ Goodman CC, Snyder TEK. Differential Diagnosis for Physical Therapists: Screening for Referral. 4th Edition. St.Louis: Saunders Elsevier; 2007.
- ↑ Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48-53.
